The Impact of Body Mass Index on Breast Reduction Outcomes: A Multi-Institutional Data Analysis of 45,000 Cases over 15 Years.
TL;DR
A significant correlation between elevated BMI and the occurrence of both surgical and medical complications after breast reduction surgery is revealed and is essential for informing preoperative counseling, refining risk assessment, and developing tailored protocols.
📈 연도별 인용 (2025–2026) · 합계 12
OpenAlex 토픽 ·
Cancer Risks and Factors
Breast Implant and Reconstruction
Global Cancer Incidence and Screening
A significant correlation between elevated BMI and the occurrence of both surgical and medical complications after breast reduction surgery is revealed and is essential for informing preoperative coun
- 표본수 (n) 61
- p-value p < 0.001
APA
Samuel Knoedler, Dany Y. Matar, et al. (2025). The Impact of Body Mass Index on Breast Reduction Outcomes: A Multi-Institutional Data Analysis of 45,000 Cases over 15 Years.. Aesthetic plastic surgery, 49(13), 3688-3702. https://doi.org/10.1007/s00266-025-04743-w
MLA
Samuel Knoedler, et al.. "The Impact of Body Mass Index on Breast Reduction Outcomes: A Multi-Institutional Data Analysis of 45,000 Cases over 15 Years.." Aesthetic plastic surgery, vol. 49, no. 13, 2025, pp. 3688-3702.
PMID
40000470
Abstract
[BACKGROUND] The caseload of breast reduction is on the rise. Despite this popularity, the association between body mass index (BMI) and postoperative outcomes remains unclear. We hypothesize that BMI is a significant determinant of postoperative morbidity after breast reduction and leverage a multi-institutional database to investigate this correlation.
[METHODS] We queried the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) (2008-2022) to identify female adult patients who underwent breast reduction. We categorized all patients into six BMI subgroups, and compared their outcomes (i.e., 30-day surgical and medical complications, reoperation, readmission, and mortality) via multivariate logistic regression analyses.
[RESULTS] 45,373 patients (mean age: 40 ± 14 years; mean BMI: 31 ± 6.1 kg/m) were identified, of whom 0.1% (n = 61) were underweight, 12% (n = 5635) healthy weight, 34% (n = 15,346) overweight, 30% (n = 13,795) had obesity I, 15% (n = 6843) obesity II, and 8.1% (n = 3693) obesity III. Overall, 2881 (6.4%) patients experienced complications, with 1936 (4.3%) cases of surgical complications and 317 (0.7%) cases of medical complications. The risk for complications increased stepwise above the healthy BMI range. Compared to women with healthy weight, patients with obesity I, II, and III had a significantly higher risk of any complication (OR 1.5, p < 0.001; OR 1.87, p < 0.001; and OR 2.6, p < 0.001, respectively), medical complications (OR 2.4, p = 0.005; OR 2.99, p = 0.001; and OR 5.2, p < 0.001, respectively), and surgical complications (OR 2.2, p < 0.001; OR 2.81, p < 0.001; and OR 4.2, p < 0.001, respectively). Overweight patients were also at higher risk for any complication (OR 1.2, p = 0.09), medical complications (OR 2.1, p = 0.02), and surgical complications (OR 1.4, p = 0.004). The odds for reoperation did not increase with higher BMI classes.
[CONCLUSION] Our multi-institutional data analysis revealed a significant correlation between elevated BMI and the occurrence of both surgical and medical complications after breast reduction surgery. The postoperative risk increased progressively with BMI above the healthy range. These findings are essential for informing preoperative counseling, refining risk assessment, and developing tailored protocols.
[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
[METHODS] We queried the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) (2008-2022) to identify female adult patients who underwent breast reduction. We categorized all patients into six BMI subgroups, and compared their outcomes (i.e., 30-day surgical and medical complications, reoperation, readmission, and mortality) via multivariate logistic regression analyses.
[RESULTS] 45,373 patients (mean age: 40 ± 14 years; mean BMI: 31 ± 6.1 kg/m) were identified, of whom 0.1% (n = 61) were underweight, 12% (n = 5635) healthy weight, 34% (n = 15,346) overweight, 30% (n = 13,795) had obesity I, 15% (n = 6843) obesity II, and 8.1% (n = 3693) obesity III. Overall, 2881 (6.4%) patients experienced complications, with 1936 (4.3%) cases of surgical complications and 317 (0.7%) cases of medical complications. The risk for complications increased stepwise above the healthy BMI range. Compared to women with healthy weight, patients with obesity I, II, and III had a significantly higher risk of any complication (OR 1.5, p < 0.001; OR 1.87, p < 0.001; and OR 2.6, p < 0.001, respectively), medical complications (OR 2.4, p = 0.005; OR 2.99, p = 0.001; and OR 5.2, p < 0.001, respectively), and surgical complications (OR 2.2, p < 0.001; OR 2.81, p < 0.001; and OR 4.2, p < 0.001, respectively). Overweight patients were also at higher risk for any complication (OR 1.2, p = 0.09), medical complications (OR 2.1, p = 0.02), and surgical complications (OR 1.4, p = 0.004). The odds for reoperation did not increase with higher BMI classes.
[CONCLUSION] Our multi-institutional data analysis revealed a significant correlation between elevated BMI and the occurrence of both surgical and medical complications after breast reduction surgery. The postoperative risk increased progressively with BMI above the healthy range. These findings are essential for informing preoperative counseling, refining risk assessment, and developing tailored protocols.
[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | breast reduction
|
유방성형술 | dict | 5 | |
| 해부 | breast
|
유방 | dict | 5 | |
| 약물 | [BACKGROUND] The
|
scispacy | 1 | ||
| 약물 | [RESULTS] 45,373 patients
|
scispacy | 1 | ||
| 질환 | obesity
|
C0028754
Obesity
|
scispacy | 1 | |
| 질환 | obesity II
|
C0028754
Obesity
|
scispacy | 1 | |
| 질환 | Overweight
|
C0497406
Overweight
|
scispacy | 1 | |
| 기타 | female
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 |
MeSH Terms
Humans; Female; Body Mass Index; Adult; Postoperative Complications; Mammaplasty; Middle Aged; Retrospective Studies; Treatment Outcome; Databases, Factual; Obesity; United States; Risk Assessment; Reoperation
📑 인용 관계
이 논문을 인용한 후속 연구 1
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (5)
- Protein as a preoperative predictor - Impact of hypoalbuminemia on 30-day outcomes of breast reduction surgery.
- Postoperative free flap monitoring in reconstructive surgery-man or machine?
- Perioperative Outcomes and Risk Profile of 4730 Cosmetic Breast Surgery Cases in Academic Institutions: An ACS-NSQIP Analysis.
- Minutes that Matter? The Significance of Operative Time in Immediate Unilateral and Bilateral Free Flap Breast Reconstruction.
- Sugar-Coated Complications? The Impact of Diabetes on Outcomes of Breast Reduction.
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.